Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)

Recent studies in cancer patients and animal models demonstrate that intestinal microbiota influence the therapeutic efficacy of cancer treatments, including immune checkpoint inhibition. However, no studies to-date have investigated relationships between gastrointestinal microbiota composition and...

Descripción completa

Detalles Bibliográficos
Autores principales: Peiffer, Lauren B., White, James R., Jones, Carli B., Slottke, Rachel E., Ernst, Sarah E., Moran, Amy E., Graff, Julie N., Sfanos, Karen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340532/
https://www.ncbi.nlm.nih.gov/pubmed/35908379
http://dx.doi.org/10.1016/j.neo.2022.100822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340532/
https://www.ncbi.nlm.nih.gov/pubmed/35908379
http://dx.doi.org/10.1016/j.neo.2022.100822

Ejemplares similares